Theravance News Breakdown

THRX -- USA Stock  

null 9.81  9.81  9,223,372,036,855%

Macroaxis does not monitor all media channels or aggregates social signals for Theravance. But even though we do not provide professional-grade financial sentiment analysis on Theravance, we do publish noise-free headlines that can be used to derive useful patterns or even a trading strategy for Theravance. Also please take a look at World Market Map.
  
a day ago at santimes.com         
Fs Capital Partners Vi Lowered Its Boot Barn Holdings Stake Theravance Biopharma s Sentiment Is 1.35
news
San Times Get full coverage
  
  
six days ago at www.streetobserver.com         
Stock Hold Signal Theravance Biopharma, Inc.
news
Street Observer Get full coverage
  
  
over a week ago at thefrugalforager.com         
Theravance Biopharma Stock Price While Sentiment Increases to 1.35
news
The Frugal ForagerTheravance Biopharma Big Money 2018 Q1 Sentiment at 1.35 The FanobTheravance Biopharma Big Money Sentiment Change at 1.35 Beyond The Ninety Minutes Get full coverage
  
  
over a week ago at www.whatsonthorold.com         
As Theravance Biopharma Market Valuation Declined, Shareholder Senzar Asset Management Has Upped ...
news
Thorold News Get full coverage
  
  
over a week ago at www.zacks.com         
Theravance Biopharma Down 1.9 percent Since Earnings Report Can It Rebound
zacks News
Zacks.comWill Theravance Biopharma Inc Ordinary Shares Run Out of Steam Soon Short Interest is Up Frisco FastballYear-to-date in the Limelight Plug Power Inc. , REV Group, Inc. , Theravance ... Stocks News Point Get full coverage
  
  
over two weeks ago at thewellesleysnews.com         
Influential Analyst Rating Changes Key Energy Services, Inc. , Theravance Biopharma, Inc.
news
Analyst Journal Get full coverage
  
  
over two weeks ago at registrarjournal.com         
Theravance Biopharma Receives Buy Rating from Needham Company LLC
news
registrarjournal.comCould Theravance Biopharma, Inc. See a Reversal After Having Formed Several Months Wedge Down Chart ... Press TelegraphTheravance Biopharmas Buy Rating Reaffirmed at Needham Company LLC Enterprise Leader Get full coverage
  
  
over two weeks ago at stocknewstimes.com         
Theravance Biopharma Given Buy Rating at Needham Company LLC
news
StockNewsTimes Get full coverage
  
  
over two weeks ago at www.thewellesleysnews.com         
Analyst Opinion Summary Social Reality, Inc. , Theravance Biopharma, Inc.
news
Analyst Journal Get full coverage
  
  
over two weeks ago at www.zacks.com         
GlaxoInnoviva File for Approval of Trelegy Ellipta in Japan
zacks News
Zacks.com Get full coverage
  
  
over two weeks ago at www.prnewswire.com         
Theravance Biopharma Highlights Submission of Regulatory Application in Japan for Once-Daily Single ...
prnewswire News
PR Newswire Get full coverage
  
  
over three weeks ago at friscofastball.com         
Analysts are on the Bearish side about Theravance Biopharma, Inc. this week.
news
Frisco FastballHow Many Theravance Biopharma, Inc. s Analysts Are Bearish Weekly RegisterDiscussion stirs around Theravance Biopharma, Inc. this week here is what analysts are saying. Gldmn Blg Get full coverage
  
  
over three weeks ago at alphabetastock.com         
Heres What to Focus on Theravance Biopharma Inc
news
Alpha Beta Stock Get full coverage
  
  
over three weeks ago at normanweekly.com         
Theravance Biopharma, Inc. Reaches 22.59 After 7.00 percent Down Move Okta Class A Shorts Raised ...
news
Norman WeeklyCrocs, Inc. Reaches 16.85 After 3.00 percent Up Move 7 Analysts Are Bullish Theravance Biopharma, Inc. TBPH ... FlintDaily.com Get full coverage
  
  
over a month ago at www.mmahotstuff.com         
Grandfield Dodd Decreased Dominion Energy Holding By 683883 Theravance Biopharma Has 1.31 Sentiment
news
MoneyMakingArticlesWeekly Theravance Biopharma, Inc. Ratings on May 17, 2018 US Index LiveNeedham Company LLC Reaffirms Buy Rating for Theravance Biopharma Macon Daily Get full coverage
  

Latest Headlines

Recently Published Macroaxis Headlines

Theravance Performance

Performance against DOW
 Price Growth (%)  
      Timeline 
1
Zacks Analysts Expect Theravance Biopharma Inc to Announce -...04/24/2018
2
Swing Trade Earnings Bullish Momentum With Options in Therav...05/06/2018
3
Theravance Biopharma, Inc. Reaches 22.59 After 7.00 percent ...05/21/2018
Also please take a look at World Market Map. Please also try Volatility Analysis module to get historical volatility and risk analysis based on latest market data.